To assess whether publication of national treatment guidelines improved the management of early RA in the UK.Incident diagnoses of RA in persons aged over 18 years from 1995 to 2010 were identified from the Clinical Practice Research Datalink. Using a natural experimental study design, interrupted time series analysis was used to assess whether trends in the proportion of patients receiving DMARDs, within 3 and 12 months of diagnosis, changed following publication of British Society for Rheumatology guidelines in 2006.Between 1995 and 2010, 11 772 incident cases of RA were identified. There was a progressive increase in the proportion of patients prescribed any DMARD within 12 months from 43.3% in 1995 to 78.5% in 2010. After publication of...
Rheumatoid arthritis (RA) is a chronic, inflammatory, auto-immune disease with an unpredictable and ...
ObjectiveTo report and synthesize patterns of disease-modifying antirheumatic drug (DMARD) use repor...
The early diagnosis of new-onset rheumatoid arthritis (RA) has become a major objective for rheumato...
To assess whether publication of national treatment guidelines improved the management of early RA i...
Objectives: to describe current disease-modifying antirheumatic drugs (DMARDs) prescription in rheum...
International audienceOBJECTIVE: To compare rheumatologists' prescription for first disease modifyin...
International audienceOBJECTIVE: To compare rheumatologists' prescription for first disease modifyin...
International audienceOBJECTIVE: To compare rheumatologists' prescription for first disease modifyin...
OBJECTIVE: RA has a substantial impact on both patients and healthcare systems. Our objective is to ...
OBJECTIVES: To describe current disease-modifying antirheumatic drugs (DMARDs) prescription in rheum...
ObjectivesTrial data have provided an evidence base to guide early treatment in RA. Few studies have...
ABSTRACT. Objective. To compare rheumatologists ’ prescription for first disease modifying antirheum...
OBJECTIVES: To describe current disease-modifying antirheumatic drugs (DMARDs) prescription in rheum...
Objectives. To describe the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment ...
Objectives. To describe the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment ...
Rheumatoid arthritis (RA) is a chronic, inflammatory, auto-immune disease with an unpredictable and ...
ObjectiveTo report and synthesize patterns of disease-modifying antirheumatic drug (DMARD) use repor...
The early diagnosis of new-onset rheumatoid arthritis (RA) has become a major objective for rheumato...
To assess whether publication of national treatment guidelines improved the management of early RA i...
Objectives: to describe current disease-modifying antirheumatic drugs (DMARDs) prescription in rheum...
International audienceOBJECTIVE: To compare rheumatologists' prescription for first disease modifyin...
International audienceOBJECTIVE: To compare rheumatologists' prescription for first disease modifyin...
International audienceOBJECTIVE: To compare rheumatologists' prescription for first disease modifyin...
OBJECTIVE: RA has a substantial impact on both patients and healthcare systems. Our objective is to ...
OBJECTIVES: To describe current disease-modifying antirheumatic drugs (DMARDs) prescription in rheum...
ObjectivesTrial data have provided an evidence base to guide early treatment in RA. Few studies have...
ABSTRACT. Objective. To compare rheumatologists ’ prescription for first disease modifying antirheum...
OBJECTIVES: To describe current disease-modifying antirheumatic drugs (DMARDs) prescription in rheum...
Objectives. To describe the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment ...
Objectives. To describe the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment ...
Rheumatoid arthritis (RA) is a chronic, inflammatory, auto-immune disease with an unpredictable and ...
ObjectiveTo report and synthesize patterns of disease-modifying antirheumatic drug (DMARD) use repor...
The early diagnosis of new-onset rheumatoid arthritis (RA) has become a major objective for rheumato...